CARMEN COE: Open Payments
NPI 1942320593 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,188 in 75 payments from 20 companies in 2025. Trend: 2023 $3,235 · 2024 $1,887 · 2025 $2,188
Food & beverage: $1,638Consulting: $550
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 24 | $386 |
| Inspire Medical Systems, Inc. | 7 | $302 |
| JAZZ PHARMACEUTICALS INC. | 7 | $245 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $220 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $200 |
| ZOLL Respicardia, Inc. | 1 | $128 |
| United Therapeutics Corporation | 4 | $113 |
| HARMONY BIOSCIENCES LLC | 4 | $74 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $70 |
Products named: TRELEGY ELLIPTA, INSPIRE, XYWAV, LUMRYZ, Adempas, remede System, Tyvaso, WAKIX.
Industry payments across TX — which companies pay providers there.
